Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 6 studies | 26% ± 8% | |
retinal bipolar neuron | 5 studies | 43% ± 4% | |
retinal cone cell | 5 studies | 33% ± 11% | |
OFF-bipolar cell | 4 studies | 34% ± 8% | |
ON-bipolar cell | 4 studies | 29% ± 9% | |
rod bipolar cell | 3 studies | 62% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 6 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 95% | 441.12 | 915 / 966 | 48% | 3.46 | 252 / 527 |
bladder | 100% | 506.48 | 21 / 21 | 38% | 3.97 | 192 / 504 |
lung | 98% | 373.35 | 568 / 578 | 39% | 9.28 | 456 / 1155 |
stomach | 71% | 398.79 | 256 / 359 | 55% | 3.73 | 157 / 286 |
breast | 98% | 523.87 | 452 / 459 | 26% | 0.48 | 289 / 1118 |
prostate | 93% | 400.12 | 227 / 245 | 22% | 0.33 | 108 / 502 |
uterus | 99% | 509.39 | 168 / 170 | 12% | 0.50 | 55 / 459 |
esophagus | 87% | 664.67 | 1258 / 1445 | 22% | 0.84 | 40 / 183 |
brain | 54% | 195.53 | 1419 / 2642 | 55% | 1.62 | 387 / 705 |
liver | 64% | 152.23 | 145 / 226 | 40% | 5.75 | 163 / 406 |
ovary | 100% | 905.20 | 180 / 180 | 3% | 0.05 | 13 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.11 | 1 / 1 |
adipose | 99% | 737.23 | 1192 / 1204 | 0% | 0 | 0 / 0 |
thymus | 90% | 348.18 | 589 / 653 | 3% | 0.05 | 19 / 605 |
blood vessel | 89% | 351.23 | 1191 / 1335 | 0% | 0 | 0 / 0 |
heart | 72% | 273.34 | 616 / 861 | 0% | 0 | 0 / 0 |
pancreas | 9% | 12.36 | 29 / 328 | 61% | 1.72 | 109 / 178 |
skin | 53% | 118.86 | 966 / 1809 | 2% | 0.04 | 9 / 472 |
kidney | 34% | 89.71 | 30 / 89 | 17% | 0.74 | 154 / 901 |
muscle | 49% | 180.67 | 390 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 31% | 84.29 | 290 / 929 | 0% | 0 | 0 / 0 |
spleen | 22% | 29.27 | 52 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 19% | 31.89 | 49 / 258 | 0% | 0.02 | 1 / 230 |
eye | 0% | 0 | 0 / 0 | 18% | 1.49 | 14 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0015813 | Biological process | L-glutamate transmembrane transport |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0015804 | Biological process | neutral amino acid transport |
GO_0001504 | Biological process | neurotransmitter uptake |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0006835 | Biological process | dicarboxylic acid transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0097060 | Cellular component | synaptic membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0015175 | Molecular function | neutral L-amino acid transmembrane transporter activity |
GO_0015501 | Molecular function | glutamate:sodium symporter activity |
GO_0005314 | Molecular function | high-affinity L-glutamate transmembrane transporter activity |
GO_0008068 | Molecular function | extracellularly glutamate-gated chloride channel activity |
GO_0005313 | Molecular function | L-glutamate transmembrane transporter activity |
Gene name | SLC1A7 |
Protein name | Amino acid transporter Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7) |
Synonyms | EAAT5 |
Description | FUNCTION: Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion . Acts primarily as an inhibitory glutamate-gated chloride channel being a major inhibitory presynaptic receptor at mammalian rod bipolar cell axon terminals. Glutamate binding gates a large Cl(-) conductance that mediates inhibition, affecting visual processing in the retina (By similarity). . |
Accessions | ENST00000611397.5 F1T0D3 ENST00000620288.4 F1T0D2 F1T0D4 ENST00000620347.5 L0C9Y3 O00341 ENST00000371494.9 [O00341-1] ENST00000371491.4 [O00341-2] ENST00000649098.1 A0A087WUF9 |